Age-related wear on joint cartilage, compounded by excess body weight, is the most common driver of osteoarthritis. But framing it as simple “wear and tear” undersells what actually happens inside the joint. Osteoarthritis involves an interplay of mechanical stress, low-grade inflammation, cellular aging, genetics, and metabolic signals from body fat, all converging on the same outcome: progressive cartilage loss and pain. The knee is the joint hit hardest, accounting for about two-thirds of new cases worldwide, and the global burden has more than doubled since 1990.
How Mechanical Stress Breaks Down Cartilage
Healthy cartilage thrives under moderate, regular loading. Walking, light jogging, and everyday movement actually help cartilage stay nourished, because the tissue has no blood supply of its own and relies on the rhythmic compression and release of movement to draw in nutrients from surrounding fluid. The trouble starts when loading becomes excessive or abnormal. Overloading triggers a cascade of destructive biochemical responses within the cartilage itself, shifting the balance from maintenance to breakdown.
When cartilage is subjected to repeated excessive force, the structural scaffold that gives it resilience begins to fragment. Those fragments activate inflammatory pathways inside the joint, prompting cells called chondrocytes to produce enzymes that chew through the very matrix they are supposed to maintain.1PubMed Central. Impact of Abnormal Mechanical Stress on Chondrocyte Death in Osteoarthritis Critically, both overuse and disuse lead to cartilage degradation. Joints that are immobilized for long periods lose cartilage quality too, though the mechanism differs from overloading.2PubMed. Mechanical loading, cartilage degradation, and arthritis The sweet spot for cartilage health is somewhere in the middle: regular, moderate activity without chronic overloading.
Why Obesity Matters Beyond Extra Weight
Excess body weight has long been recognized as one of the strongest modifiable risk factors for osteoarthritis, especially at the knee. The intuitive explanation is straightforward: more weight means more force transmitted through load-bearing joints with every step. But the relationship between obesity and osteoarthritis goes well beyond mechanics.
A clue comes from the hands. Obesity is also linked to osteoarthritis in the fingers and wrists, joints that bear almost none of a person’s body weight.3Heliyon. Beyond mechanical loading: The metabolic contribution of obesity in osteoarthritis unveils novel therapeutic targets That association makes little sense if extra pounds are the only problem. The explanation lies in what fat tissue does metabolically. Adipose tissue is not inert storage; it is an active endocrine organ that pumps out inflammatory molecules called adipokines, along with pro-inflammatory cytokines and enzymes that break down cartilage matrix.4PubMed Central. Obesity-Related Knee Osteoarthritis-Current Concepts People carrying extra body fat live in a state of chronic, low-level systemic inflammation, and their joints are caught in the crossfire.
Dyslipidemia, meaning abnormal blood fat levels, also appears to play a role independent of body weight itself. Disturbed lipid metabolism and the chronic inflammatory environment created by excess adipose tissue each contribute to cartilage damage.5Rheumatology. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis A Mendelian randomization study using UK Biobank data confirmed a causal link between genetically higher body mass index and osteoarthritis risk at the knee and hip, though not at the hand.6PubMed Central. Causal Factors for Knee, Hip, and Hand Osteoarthritis: A Mendelian Randomization Study in the UK Biobank That discrepancy is interesting: it suggests the mechanical burden of weight matters more for large weight-bearing joints, while the metabolic inflammatory pathway may drive hand involvement through a different route.
Cellular Aging and the Senescent Secretory Problem
Aging is the single largest non-modifiable risk factor for osteoarthritis, but the connection is not as simple as decades of use grinding cartilage down like brake pads. Cartilage cells age in their own specific way, and as they do, they become actively destructive.
Chondrocytes from older adults increasingly display a pattern called the senescent secretory phenotype. Instead of quietly dividing or maintaining their surroundings, these cells start overproducing inflammatory molecules and cartilage-degrading enzymes. Compared to chondrocytes isolated from young donors, those from older adults secrete significantly more of a key enzyme that cleaves type II collagen, the main structural protein in cartilage.7Osteoarthritis and Cartilage. Aging and osteoarthritis The more senescent cells accumulate, the more damage they inflict on the tissue around them, creating a self-reinforcing loop of degradation.
Animal experiments have sharpened this picture. In mouse models, selectively clearing senescent chondrocytes from injured joints slowed the development of osteoarthritis, and injecting senescent cells into healthy joints actually induced it.8PubMed Central. Senescence in osteoarthritis: from mechanism to potential treatment That finding has fueled research interest in “senolytic” drugs, compounds that selectively destroy senescent cells, as potential treatments.
Inflammation Starts Earlier Than Most People Think
For decades, osteoarthritis was classified as a non-inflammatory, purely degenerative condition, a label that distinguished it from rheumatoid arthritis and other autoimmune joint diseases. That framing is outdated. Inflammation is now recognized as a central driver of osteoarthritis, though it is different in character from the inflammation seen in autoimmune disease: chronic, low-grade, and driven by the innate immune system rather than by antibodies attacking the joint.9PubMed Central. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis
The synovium, the thin membrane lining the inside of the joint capsule, becomes inflamed even in early-stage osteoarthritis. Synovial inflammation has been linked to both structural progression seen on imaging and worsening pain.10PubMed Central. Synovial inflammation in osteoarthritis progression Some researchers have proposed that inflammatory signaling within the synovium is not just a side effect of cartilage damage but may actually be the initial trigger that sets structural and functional deterioration in motion across the entire joint.11PubMed Central. Innate Immunity and Synovitis: Key Players in Osteoarthritis Progression This is a meaningful shift in thinking. If inflammation comes first and drives the cartilage loss rather than the other way around, it opens the door to treatments aimed at cooling the inflammation before irreversible structural damage sets in.
Joint Injuries and Post-Traumatic Osteoarthritis
A severe joint injury, especially a torn anterior cruciate ligament in the knee, substantially raises the long-term odds of developing osteoarthritis. Studies suggest that roughly half of people who tear an ACL will develop symptomatic osteoarthritis in that knee within ten to fifteen years.12PubMed Central. The role of ACL injury in the development of posttraumatic knee osteoarthritis Because most ACL tears happen in people under 30, this means onset of painful, disabling arthritis during their 30s and 40s, decades earlier than the typical age-related pattern.
Post-traumatic osteoarthritis involves a mix of structural instability, altered joint mechanics, biological changes triggered by the initial injury, and neuromuscular deficits that persist even after surgical reconstruction.13PubMed Central. Post-traumatic osteoarthritis following ACL injury The impact of the injury itself can damage cartilage and bone at a microscopic level, and the subsequent instability changes how forces are distributed across the joint surface with every movement. Even with successful surgical repair, the joint rarely returns to its pre-injury mechanical state, which is one reason why post-surgical rehabilitation focuses so heavily on muscle strengthening and movement retraining.
The Genetic Component
Osteoarthritis runs in families, and twin studies have estimated that genetic factors account for a significant proportion of susceptibility. Genome-wide studies have now identified over 100 DNA variants linked to the disease, and collectively these variants account for more than 20 percent of its heritability.14PubMed Central. Genetics of osteoarthritis Most of these variants do not change protein structure directly. Instead, they sit in regulatory regions of the genome, where they are thought to influence how much or how little certain genes are expressed in joint tissues.15PubMed. Risk factors for osteoarthritis: genetics
Genetics also shows that osteoarthritis is not one uniform disease. The genetic factors predisposing someone to knee osteoarthritis overlap surprisingly little with those driving hip osteoarthritis. Hand osteoarthritis appears to share some genetic architecture across finger joints but is largely distinct from large-joint disease.16Rheumatology. The genetic influence on radiographic osteoarthritis is site specific at the hand, hip and knee This site-specificity suggests that when we talk about “the cause” of osteoarthritis, we might be talking about partially different diseases depending on which joint is affected.
Sex, Hormones, and the Post-Menopausal Spike
Women are more likely than men to develop osteoarthritis, and the disparity widens sharply after menopause. The prevalence of osteoarthritis increases dramatically in women during the years following menopause, and a particularly painful form of hand osteoarthritis is closely associated with estrogen loss during this period.17PubMed. The effects of estrogen on osteoarthritis These patterns have led researchers to investigate how estrogen protects joint tissues and what happens when that protection drops.
The picture is still coming into focus. Articular tissues were once considered unresponsive to estrogen, but there is now growing evidence that estrogen influences joint cells through multiple molecular pathways.18PubMed Central. Osteoarthritis associated with estrogen deficiency Understanding these pathways could eventually inform targeted treatments for postmenopausal women, a group that carries a disproportionate share of the global osteoarthritis burden.
Alignment, Occupation, and Muscle Strength
How your joint is aligned matters. A knee that bows inward (valgus alignment) or outward (varus alignment) distributes weight unevenly across the cartilage surface. Varus alignment increases the risk of developing knee osteoarthritis altogether, while valgus alignment raises the risk of progression and cartilage damage on the outer side of the knee.19PubMed Central. Valgus Malalignment is a Risk Factor for Lateral Knee Osteoarthritis Incidence and Progression: Findings from MOST and the Osteoarthritis Initiative In people who already have some osteoarthritis, malalignment in either direction tends to accelerate damage in the compartment receiving more load while, counterintuitively, sparing the other side.20Annals of the Rheumatic Diseases. Varus and valgus alignment and incident and progressive knee osteoarthritis
Certain occupations pile on risk, too. Jobs that combine heavy lifting with prolonged kneeling or squatting are consistently linked to higher rates of knee osteoarthritis. A systematic review found moderate evidence for this combination, with the added risk ranging widely depending on the study but reliably elevated.21PubMed Central. Occupational physical loading tasks and knee osteoarthritis: a review of the evidence Meta-analyses have quantified specific occupational risk factors: lifting loads over 10 kilograms per week, squatting or kneeling, standing for more than two hours daily, and extensive walking all independently raise the odds.22PubMed. Risk factors for development of lower limb osteoarthritis in physically demanding occupations: A systematic review and meta-analysis For hip osteoarthritis, heavy lifting is the standout occupational contributor.
Muscle weakness, particularly of the quadriceps, is another underappreciated risk factor. The quadriceps acts as the knee’s shock absorber and primary stabilizer. People with knee osteoarthritis consistently have weaker quadriceps than those without it, and the weakness is not just a consequence of pain or disuse: it can precede the disease. A meta-analysis found that people with weak knee extensors faced about 65 percent higher odds of developing symptomatic knee osteoarthritis.23PubMed. Knee extensor muscle weakness is a risk factor for development of knee osteoarthritis. A systematic review and meta-analysis Among women with existing osteoarthritis, the weakness was present even in those with normal muscle mass, suggesting it is at least partly a neuromuscular problem rather than simply muscle wasting.24PubMed. Quadriceps weakness and osteoarthritis of the knee
Why the Knee Gets Hit Hardest
Globally, roughly 595 million people were living with osteoarthritis as of 2020, about 7.6 percent of the world’s population.25The Lancet. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Of the recognized subtypes, the knee dominates. It accounts for about 66 percent of incident cases and 56 percent of the disability burden, followed by hand osteoarthritis at roughly 22 percent of new cases.26Scientific Reports. Osteoarthritis burden and inequality from 1990 to 2021: a systematic analysis for the global burden of disease Study 2021 Hip osteoarthritis, despite being clinically severe, is less common by the numbers.
One reason the knee is so vulnerable may trace back millions of years. When human ancestors transitioned to walking upright, the knee had to adapt to entirely new biomechanical demands. Researchers have found that during human evolution, the knee adapted to bipedalism by altering the developmental programs of chondrocytes, the cells that build and maintain cartilage. That adaptation came with a cost: the very genetic regions that were reshaped for bipedal walking now overlap with the DNA variants associated with osteoarthritis risk today.27PubMed Central. Evolutionary Selection and Constraint on Human Knee Chondrocyte Regulation Impacts Osteoarthritis Risk In other words, the evolutionary trade-off that gave us the ability to walk and run on two legs may have baked osteoarthritis susceptibility into the human knee.
This evolutionary angle is bolstered by comparative research. Chronic musculoskeletal conditions are common in humans and likely affected our prehistoric ancestors, but they are rarer in our closest quadrupedal relatives. Some researchers have proposed that the transition to bipedalism roughly six to eight million years ago constituted an early mismatch scenario, increasing susceptibility to joint problems as a trade-off for the advantages of upright walking and the foraging and reproductive benefits it brought.28PubMed Central. Contemporary small-scale subsistence populations offer unique insights into human musculoskeletal health and aging
What Happens Beneath the Cartilage
Osteoarthritis is often described as a disease of cartilage, but the bone just beneath the cartilage surface, called subchondral bone, is deeply involved. Subchondral sclerosis, a thickening and hardening of this bone layer, is a hallmark of the disease and shows up on standard X-rays. Paradoxically, the bone becomes denser in volume but is actually less well mineralized than healthy bone because of frantic, disorganized remodeling.29PubMed Central. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes
This abnormal remodeling is driven by persistent abnormal mechanical stresses causing tiny fractures in the subchondral bone and at the junction between bone and cartilage. The body’s repair response involves new bone formation, but the new bone is structurally inferior and contributes to osteophyte growth, the bony spurs visible on imaging that are so characteristic of advanced osteoarthritis.30PubMed Central. Subchondral bone remodelling in osteoarthritis Meanwhile, lesions within the bone marrow at these sites are associated with pain sensitization and inflammatory signaling.31Bone Research. Subchondral bone microenvironment in osteoarthritis and pain This matters practically because it explains why osteoarthritis pain does not always correlate neatly with how much cartilage has been lost. Some people with severe cartilage loss on imaging have little pain, while others with modest changes are in agony.
The Pain Disconnect
That poor correlation between what imaging shows and how much pain someone feels is one of the more frustrating aspects of osteoarthritis for both patients and clinicians. Two people with identical-looking X-rays can report vastly different pain levels, and the mismatch has prompted investigation into how the central nervous system processes osteoarthritis pain. Brain imaging studies have identified multiple areas of the brain involved in processing osteoarthritis pain, revealing that the experience is shaped not only by what is happening locally in the joint but also by central pain-processing pathways that can amplify or dampen the signal.32Rheumatology. What makes osteoarthritis painful? The evidence for local and central pain processing This phenomenon, sometimes called central sensitization, means that for some people with osteoarthritis, the nervous system itself has become part of the problem. Treating only the joint may not fully resolve their pain.
The Gut-Joint Connection
An emerging and still speculative frontier in osteoarthritis research is the so-called gut-joint axis. The idea is that imbalances in gut bacteria (dysbiosis) may contribute to the chronic low-grade inflammation that feeds osteoarthritis. Observational research has found links between gut dysbiosis and conditions that worsen osteoarthritis, such as obesity and elevated uric acid levels. These connections appear to involve increased intestinal permeability, allowing bacterial products to leak into the bloodstream and stoke systemic inflammation.33PubMed Central. Gut microbiota and osteoarthritis: epidemiology, mechanistic analysis, and new horizons for pharmacological interventions
In animal models, this pathway has been demonstrated more directly. Disrupting the gut microbiome in mice led to a breakdown of the intestinal barrier, a surge in circulating bacterial toxins, and measurably worse osteoarthritis, including accelerated cartilage degeneration, more osteophyte formation, and reduced bone density.34PubMed Central. Gut microbiome dysbiosis accelerates osteoarthritis progression by inducing IFP-SM inflammation in “double-hit” mice The findings in humans remain correlational, and definitive causal proof is still lacking. But the research is interesting enough that some scientists now consider gut health a plausible modifiable factor in osteoarthritis, one that could eventually be targeted through probiotics or dietary interventions if the causal chain holds up in clinical trials.
Disease-Modifying Drugs on the Horizon
Currently, there is no approved drug that slows or reverses the structural progression of osteoarthritis. Existing treatments manage symptoms: pain relievers, anti-inflammatory drugs, physical therapy, and eventually joint replacement when those stop working. But a growing number of experimental approaches aim to change that. Disease-modifying osteoarthritis drugs in various stages of investigation include therapies targeting inflammatory cytokines, enzyme inhibitors designed to slow cartilage breakdown, growth factors that stimulate cartilage repair, gene therapies, and senolytic agents meant to clear the senescent cells described earlier in this article.35PubMed Central. The Current Role of Disease-modifying Osteoarthritis Drugs None has yet crossed the finish line of regulatory approval for osteoarthritis specifically, but the pipeline reflects the broader shift in understanding: if osteoarthritis is driven by inflammation, cellular senescence, and metabolic dysfunction rather than simple mechanical wear, it should be possible to intervene at those biological levels rather than waiting until the joint is destroyed.